CoChat

Senescent Cells: A Therapeutic Target in Cardiovascular Diseases

Open access
Suda, Masayoshi, Paul, Karl H., Minamino, Tohru, Miller, Jordan D., Lerman, Amir, Ellison-Hughes, Georgina M., Tchkonia, Tamar, Kirkland, James L. · 2023 · Cells
Cited by 112

The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.

Abstract

Senescent cell accumulation has been observed in age-associated diseases including cardiovascular diseases. Senescent cells lack proliferative capacity and secrete senescence-associated secretory phenotype (SASP) factors that may cause or worsen many cardiovascular diseases. Therapies targeting senescent cells, especially senolytic drugs that selectively induce senescent cell removal, have been shown to delay, prevent, alleviate, or treat multiple age-associated diseases in preclinical models. Some senolytic clinical trials have already been completed or are underway for a number of diseases and geriatric syndromes. Understanding how cellular senescence affects the various cell types in the cardiovascular system, such as endothelial cells, vascular smooth muscle cells, fibroblasts, immune cells, progenitor cells, and cardiomyocytes, is important to facilitate translation of senotherapeutics into clinical interventions. This review highlights: (1) the characteristics of senescent cells and their involvement in cardiovascular diseases, focusing on the aforementioned cardiovascular cell types, (2) evidence about senolytic drugs and other senotherapeutics, and (3) the future path and clinical potential of senotherapeutics for cardiovascular diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells12091296

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 164

  1. Yu, 2021, Quercetin Reverses Cardiac Systolic Dysfunction in Mice Fed with a High-Fat Diet: Role of Angiogenesis, Oxid. Med. Cell. Longev., 2021, 8875729, 10.1155/2021/8875729 · DOI · Paper page
  2. Gunasekaran, 2011, Type 2 diabetes and the aging pancreatic beta cell, Aging, 3, 565, 10.18632/aging.100350 · DOI · Paper page
  3. Palmer, 2022, Targeting cellular senescence in metabolic disease, Mol. Metab., 66, 101601, 10.1016/j.molmet.2022.101601 · DOI
  4. Chaib, 2022, Obesity, Senescence, and Senolytics, Handb. Exp. Pharmacol., 274, 165, 10.1007/164_2021_555 · DOI · Paper page
  5. Conley, 2020, Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Front. Cell Dev. Biol., 8, 197, 10.3389/fcell.2020.00197 · DOI · Paper page
  6. Escande, 2014, Deleted in Breast Cancer 1 regulates cellular senescence during obesity, Aging Cell, 13, 951, 10.1111/acel.12235 · DOI · Paper page
  7. Meijnikman, 2022, Hyperinsulinemia Is Highly Associated With Markers of Hepatocytic Senescence in Two Independent Cohorts, Diabetes, 71, 1929, 10.2337/db21-1076 · DOI
  8. Nalysnyk, 2012, Incidence and prevalence of idiopathic pulmonary fibrosis: Review of the literature, Eur. Respir. Rev., 21, 355, 10.1183/09059180.00002512 · DOI · Paper page
  9. Parikh, 2019, Hyperoxia-induced Cellular Senescence in Fetal Airway Smooth Muscle Cells, Am. J. Respir. Cell Mol. Biol., 61, 51, 10.1165/rcmb.2018-0176OC · DOI · Paper page
  10. Bian, 2019, Senescence marker activin A is increased in human diabetic kidney disease: Association with kidney function and potential implications for therapy, BMJ Open. Diabetes Res. Care, 7, e000720, 10.1136/bmjdrc-2019-000720 · DOI · Paper page
  11. Farr, 2019, Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans, J. Bone Miner. Res., 34, 1407, 10.1002/jbmr.3729 · DOI · Paper page
  12. Chirinos, J.A. (2022). Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease, Academic Press. · DOI
  13. Hwang, H.J., Kim, N., Herman, A.B., Gorospe, M., and Lee, J.S. (2022). Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging. Int. J. Mol. Sci., 23. · DOI
  14. Yoshida, Y., Hayashi, Y., Suda, M., Tateno, K., Okada, S., Moriya, J., Yokoyama, M., Nojima, A., Yamashita, M., and Kobayashi, Y. (2014). Notch Signaling Regulates the Lifespan of Vascular Endothelial Cells via a p16-Dependent Pathway. PLoS ONE, 9. · DOI
  15. Kunieda, 2006, Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway, Circulation, 114, 953, 10.1161/CIRCULATIONAHA.106.626606 · DOI · Paper page
  16. Miyauchi, 2004, Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway, EMBO J., 23, 212, 10.1038/sj.emboj.7600045 · DOI · Paper page
  17. Breitschopf, 2001, Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism, FEBS Lett., 493, 21, 10.1016/S0014-5793(01)02272-4 · DOI · Paper page
  18. Rajendran, 2019, Autophagy and senescence: A new insight in selected human diseases, J. Cell. Physiol., 234, 21485, 10.1002/jcp.28895 · DOI · Paper page
  19. Bernadotte, 2016, Markers of cellular senescence. Telomere shortening as a marker of cellular senescence, Aging, 8, 3, 10.18632/aging.100871 · DOI · Paper page
  20. Hu, 2022, Cellular Senescence in Cardiovascular Diseases: A Systematic Review, Aging Dis., 13, 103, 10.14336/AD.2021.0927 · DOI · Paper page
  21. Conover, 2022, Senescence induces proteolytically-active PAPP-A secretion and association with extracellular vesicles in human pre-adipocytes, Exp. Gerontol., 172, 112070, 10.1016/j.exger.2022.112070 · DOI
  22. Conover, 2012, Key questions and answers about pregnancy-associated plasma protein-A, Trends Endocrinol. Metab., 23, 242, 10.1016/j.tem.2012.02.008 · DOI · Paper page
  23. Conover, 2015, Pregnancy-associated plasma protein-A deficiency improves survival of mice on a high fat diet, Exp. Gerontol., 70, 131, 10.1016/j.exger.2015.08.007 · doi:10.1016/j.exger.2015.08.007
  24. Conover, 2013, Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet, Am. J. Physiol. Endocrinol. Metab., 305, E1145, 10.1152/ajpendo.00405.2013 · DOI
  25. Bale, 2017, Inducible knockdown of pregnancy-associated plasma protein-A gene expression in adult female mice extends life span, Aging Cell, 16, 895, 10.1111/acel.12624 · DOI
  26. Tanaka, 2021, Senescence-associated extracellular vesicle release plays a role in senescence-associated secretory phenotype (SASP) in age-associated diseases, J. Biochem., 169, 147, 10.1093/jb/mvaa109 · DOI
  27. Misawa, T., Hitomi, K., Miyata, K., Tanaka, Y., Fujii, R., Chiba, M., Loo, T.M., Hanyu, A., Kawasaki, H., and Kato, H. (2023). Identification of Novel Senescent Markers in Small Extracellular Vesicles. Int. J. Mol. Sci., 24. · DOI
  28. Munk, 2017, Senescence-Associated MicroRNAs, Int. Rev. Cell Mol. Biol., 334, 177, 10.1016/bs.ircmb.2017.03.008 · DOI
  29. Sato, 2022, CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury, Journal. Clin. Investig., 132, e146071, 10.1172/JCI146071 · DOI · Paper page
  30. Toya, 2021, Vascular Aging Detected by Peripheral Endothelial Dysfunction Is Associated With ECG-Derived Physiological Aging, J. Am. Heart Assoc., 10, e018656, 10.1161/JAHA.120.018656 · DOI
  31. Kotla, 2019, Endothelial senescence is induced by phosphorylation and nuclear export of telomeric repeat binding factor 2-interacting protein, JCI Insight, 4, e124867, 10.1172/jci.insight.124867 · DOI
  32. Mortuza, R., Chen, S., Feng, B., Sen, S., and Chakrabarti, S. (2013). High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS ONE, 8. · DOI · Paper page
  33. Liu, 2020, Glucose-induced oxidative stress and accelerated aging in endothelial cells are mediated by the depletion of mitochondrial SIRTs, Physiol. Rep., 8, e14331, 10.14814/phy2.14331 · DOI · Paper page
  34. Clayton, 2020, Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment, Cardio Oncol., 2, 475
  35. Clayton, 2021, Tumor Necrosis Factor Alpha-Mediated Inflammation and Remodeling of the Extracellular Matrix Underlies Aortic Stiffening Induced by the Common Chemotherapeutic Agent Doxorubicin, Hypertension, 77, 1581, 10.1161/HYPERTENSIONAHA.120.16759 · DOI
  36. Dagher, 2021, Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass Graft Surgery, Front. Cardiovasc. Med., 8, 741542, 10.3389/fcvm.2021.741542 · DOI
  37. Vasa, 2000, Nitric oxide activates telomerase and delays endothelial cell senescence, Circ. Res., 87, 540, 10.1161/01.RES.87.7.540 · DOI · Paper page
  38. Yokoyama, 2019, p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia, J. Mol. Cell. Cardiol., 129, 105, 10.1016/j.yjmcc.2019.02.010 · DOI
  39. Yokoyama, 2014, Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity, Cell Rep., 7, 1691, 10.1016/j.celrep.2014.04.046 · DOI · Paper page
  40. Hayashi, 2006, Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes, Proc. Natl. Acad. Sci. USA, 103, 17018, 10.1073/pnas.0607873103 · DOI · Paper page
  41. Bloom, 2023, Mechanisms and consequences of endothelial cell senescence, Nat. Rev. Cardiol., 20, 38, 10.1038/s41569-022-00739-0 · DOI · Paper page
  42. Donato, 2009, Vascular endothelial dysfunction with aging: Endothelin-1 and endothelial nitric oxide synthase, Am. J. Physiol.-Heart Circ. Physiol., 297, H425, 10.1152/ajpheart.00689.2008 · DOI · Paper page
  43. 2001, The endothelium as a metabolic and endocrine organ: Its relation with insulin resistance, Exp. Clin. Endocrinol. Diabetes, 109, S166, 10.1055/s-2001-18579 · doi:10.1055/s-2001-18579
  44. Garfinkel, 1994, Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells, Proc. Natl. Acad. Sci. USA, 91, 1559, 10.1073/pnas.91.4.1559 · DOI · Paper page
  45. Matacchione, 2021, Anti-SASP and anti-inflammatory activity of resveratrol, curcumin and β-caryophyllene association on human endothelial and monocytic cells, Biogerontology, 22, 297, 10.1007/s10522-021-09915-0 · DOI
  46. Culley, 2021, Frataxin deficiency promotes endothelial senescence in pulmonary hypertension, J. Clin. Investig., 131, e136459, 10.1172/JCI136459 · DOI
  47. Chang, 2013, Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells, Int. J. Mol. Med., 31, 1202, 10.3892/ijmm.2013.1300 · DOI
  48. Suda, M., Shimizu, I., Yoshida, Y., Hayashi, Y., Ikegami, R., Katsuumi, G., Wakasugi, T., Yoshida, Y., Okuda, S., and Soga, T. (2017). Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway. PLoS ONE, 12. · DOI
  49. Sano, 2007, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload, Nature, 446, 444, 10.1038/nature05602 · DOI · Paper page
  50. Chi, 2019, Vascular smooth muscle cell senescence and age-related diseases: State of the art, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 1810, 10.1016/j.bbadis.2018.08.015 · DOI · Paper page
  51. Bennett, 1998, Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques, Circ. Res., 82, 704, 10.1161/01.RES.82.6.704 · DOI · Paper page
  52. Yu, 2016, The role of mitochondrial DNA damage in the development of atherosclerosis, Free. Radic. Biol. Med., 100, 223, 10.1016/j.freeradbiomed.2016.06.011 · DOI
  53. Canugovi, 2019, Increased mitochondrial NADPH oxidase 4 (NOX4) expression in aging is a causative factor in aortic stiffening, Redox Biol., 26, 101288, 10.1016/j.redox.2019.101288 · DOI
  54. Otuki, 2018, Effects of Direct Oral Anticoagulants at the Peak Phase, Trough Phase, and After Vascular Injury, J. Am. Coll. Cardiol., 71, 102, 10.1016/j.jacc.2017.10.076 · doi:10.1016/j.jacc.2017.10.076
  55. Hayashi, 2022, Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity, iScience, 25, 104547, 10.1016/j.isci.2022.104547 · DOI
  56. Bennett, 2016, Basic research: Killing the old: Cell senescence in atherosclerosis, Nat. Rev. Cardiol., 14, 8, 10.1038/nrcardio.2016.195 · DOI
  57. Furuuchi, 2022, Endothelial SIRT-1 has a critical role in the maintenance of capillarization in brown adipose tissue, iScience, 25, 105424, 10.1016/j.isci.2022.105424 · DOI
  58. Grootaert, 2021, SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis, Circ. Res., 128, 474, 10.1161/CIRCRESAHA.120.318353 · DOI · Paper page
  59. Gardner, 2015, Senescent Vascular Smooth Muscle Cells Drive Inflammation Through an Interleukin-1α-Dependent Senescence-Associated Secretory Phenotype, Arterioscler. Thromb. Vasc. Biol., 35, 1963, 10.1161/ATVBAHA.115.305896 · DOI · Paper page
  60. Soto, 2014, Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly, Ageing Res. Rev., 18, 132, 10.1016/j.arr.2014.10.001 · DOI
  61. Lacolley, 2017, Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease, Physiol. Rev., 97, 1555, 10.1152/physrev.00003.2017 · DOI · Paper page
  62. Lacolley, 2018, Smooth muscle cell and arterial aging: Basic and clinical aspects, Cardiovasc. Res., 114, 513, 10.1093/cvr/cvy009 · DOI · Paper page
  63. Schurgers, 2018, Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles, Front. Cardiovasc. Med., 5, 36, 10.3389/fcvm.2018.00036 · DOI
  64. Ikeda, 2009, Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition, Am. J. Physiol. Heart Circ. Physiol., 297, H1673, 10.1152/ajpheart.00455.2009 · DOI · Paper page
  65. Huang, 2020, Carnosine attenuates vascular smooth muscle cells calcification through mTOR signaling pathway, Aging Med., 3, 153, 10.1002/agm2.12125 · DOI
  66. Wakasugi, T., Shimizu, I., Yoshida, Y., Hayashi, Y., Ikegami, R., Suda, M., Katsuumi, G., Nakao, M., Hoyano, M., and Kashimura, T. (2019). Role of smooth muscle cell p53 in pulmonary arterial hypertension. PLoS ONE, 14. · DOI
  67. Ball, 2005, Telomere-independent cellular senescence in human fetal cardiomyocytes, Aging Cell, 4, 21, 10.1111/j.1474-9728.2004.00137.x · DOI
  68. Mitry, 2020, Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity, Am. J. Physiol. Cell Physiol., 318, C380, 10.1152/ajpcell.00073.2019 · DOI
  69. Zhang, 2007, Hypoxia reoxygenation induces premature senescence in neonatal SD rat cardiomyocytes, Acta Pharmacol. Sin., 28, 44, 10.1111/j.1745-7254.2007.00488.x · DOI
  70. Nomura, 2018, Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure, Nat. Commun., 9, 4435, 10.1038/s41467-018-06639-7 · DOI · Paper page
  71. Spallarossa, 2009, Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2, Am. J. Physiol. Heart Circ. Physiol., 297, H2169, 10.1152/ajpheart.00068.2009 · DOI · Paper page
  72. Maejima, 2008, Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage, Aging Cell, 7, 125, 10.1111/j.1474-9726.2007.00358.x · DOI · Paper page
  73. Massion, 2003, Nitric Oxide and Cardiac Function, Circ. Res., 93, 388, 10.1161/01.RES.0000088351.58510.21 · DOI · Paper page
  74. Shimizu, 2012, p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure, Cell Metab., 15, 51, 10.1016/j.cmet.2011.12.006 · DOI · Paper page
  75. Tang, 2020, Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments, Front. Endocrinol., 11, 280, 10.3389/fendo.2020.00280 · DOI · Paper page
  76. Cui, 2018, Postinfarction Hearts Are Protected by Premature Senescent Cardiomyocytes Via GATA 4-Dependent CCN 1 Secretion, J. Am. Heart Assoc., 7, e009111, 10.1161/JAHA.118.009111 · DOI · Paper page
  77. Zhang, 2019, Trimetazidine and l-carnitine prevent heart aging and cardiac metabolic impairment in rats via regulating cardiac metabolic substrates, Exp. Gerontol., 119, 120, 10.1016/j.exger.2018.12.019 · DOI
  78. Dillon, 2012, The role of PGC-1 coactivators in aging skeletal muscle and heart, IUBMB Life, 64, 231, 10.1002/iub.608 · DOI · Paper page
  79. Mailleux, 2018, AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation, Nat. Commun., 9, 374, 10.1038/s41467-017-02795-4 · DOI · Paper page
  80. Tang, 2017, SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy, Circulation, 136, 2051, 10.1161/CIRCULATIONAHA.117.028728 · DOI · Paper page
  81. Kane, 2018, Sirtuins and NAD(+) in the Development and Treatment of Metabolic and Cardiovascular Diseases, Circ. Res., 123, 868, 10.1161/CIRCRESAHA.118.312498 · DOI · Paper page
  82. Burke, 1997, Coronary risk factors and plaque morphology in men with coronary disease who died suddenly, N. Engl. J. Med., 336, 1276, 10.1056/NEJM199705013361802 · DOI · Paper page
  83. Libby, 2008, Diversity of Denizens of the Atherosclerotic Plaque, Circulation, 117, 3168, 10.1161/CIRCULATIONAHA.108.783068 · DOI · Paper page
  84. Newby, 2009, Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes, Thromb. Haemost., 101, 1006, 10.1160/TH08-07-0469 · DOI · Paper page
  85. Johnson, 2006, Vascular calcification: Pathobiological mechanisms and clinical implications, Circ. Res., 99, 1044, 10.1161/01.RES.0000249379.55535.21 · DOI · Paper page
  86. Allahverdian, 2018, Smooth muscle cell fate and plasticity in atherosclerosis, Cardiovasc. Res., 114, 540, 10.1093/cvr/cvy022 · DOI · Paper page
  87. Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science, 354, 472, 10.1126/science.aaf6659 · DOI · Paper page
  88. Richardson, 2018, Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells, Arterioscler. Thromb. Vasc. Biol., 38, 1283, 10.1161/ATVBAHA.117.309940 · DOI
  89. Bernal, 2019, T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors, Antiviral Res., 162, 163, 10.1016/j.antiviral.2018.12.014 · DOI
  90. Yu, 2016, T cell senescence and cardiovascular diseases, Clin. Exp. Med., 16, 257, 10.1007/s10238-015-0376-z · DOI · Paper page
  91. Varricchi, 2020, The emerging role of T follicular helper (T(FH)) cells in aging: Influence on the immune frailty, Ageing Res. Rev., 61, 101071, 10.1016/j.arr.2020.101071 · DOI
  92. Bazioti, 2022, T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice, Nat. Commun., 13, 3799, 10.1038/s41467-022-31135-4 · DOI · Paper page
  93. Youn, 2013, Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension, Hypertension, 62, 126, 10.1161/HYPERTENSIONAHA.113.00689 · DOI · Paper page
  94. Youn, 2015, Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction, Cell. Mol. Immunol., 12, 466, 10.1038/cmi.2014.74 · DOI
  95. Kaplan, 2011, T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women, J. Infect. Dis., 203, 452, 10.1093/infdis/jiq071 · DOI · Paper page
  96. Liuzzo, 2007, Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events, J. Am. Coll. Cardiol., 50, 1450, 10.1016/j.jacc.2007.06.040 · DOI · Paper page
  97. Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 · DOI · Paper page
  98. Takahashi, 1999, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat. Med., 5, 434, 10.1038/7434 · DOI · Paper page
  99. Werner, 2006, Clinical and therapeutical implications of EPC biology in atherosclerosis, J. Cell. Mol. Med., 10, 318, 10.1111/j.1582-4934.2006.tb00402.x · DOI
  100. Vasa, 2001, Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, Circ. Res., 89, E1, 10.1161/hh1301.093953 · DOI · Paper page
  101. Yang, 1999, Human endothelial cell life extension by telomerase expression, J. Biol. Chem., 274, 26141, 10.1074/jbc.274.37.26141 · DOI · Paper page
  102. Torella, 2004, Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression, Circ. Res., 94, 514, 10.1161/01.RES.0000117306.10142.50 · DOI · Paper page
  103. Cesselli, 2011, Effects of age and heart failure on human cardiac stem cell function, Am. J. Pathol., 179, 349, 10.1016/j.ajpath.2011.03.036 · DOI · Paper page
  104. Castaldi, 2017, Decline in cellular function of aged mouse c-kit(+) cardiac progenitor cells, J. Physiol., 595, 6249, 10.1113/JP274775 · DOI
  105. Marino, 2022, Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age, Diabetes, 71, 1081, 10.2337/db21-0536 · DOI
  106. Zhu, F., Li, Y., Zhang, J., Piao, C., Liu, T., Li, H.H., and Du, J. (2013). Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS ONE, 8. · DOI · Paper page
  107. Jia, 2017, Haplodeficiency of Ataxia Telangiectasia Mutated Accelerates Heart Failure After Myocardial Infarction, J. Am. Heart Assoc., 6, e006349, 10.1161/JAHA.117.006349 · DOI · Paper page
  108. Li, K., Li, Y., Yu, Y., Ding, J., Huang, H., Chu, C., Hu, L., Yu, Y., Cao, Y., and Xu, P. (2021). Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension. BMC Pulm. Med., 21. · DOI
  109. Roger, I., Milara, J., Belhadj, N., and Cortijo, J. (2021). Senescence Alterations in Pulmonary Hypertension. Cells, 10. · DOI
  110. Sawaki, 2018, Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production, Circulation, 138, 809, 10.1161/CIRCULATIONAHA.117.031358 · DOI · Paper page
  111. Kamo, 2015, Cardiac nonmyocytes in the hub of cardiac hypertrophy, Circ. Res., 117, 89, 10.1161/CIRCRESAHA.117.305349 · DOI · Paper page
  112. Kakkar, 2010, Intramyocardial fibroblast myocyte communication, Circ. Res., 106, 47, 10.1161/CIRCRESAHA.109.207456 · DOI · Paper page
  113. Civitarese, 2017, Role of integrins in mediating cardiac fibroblast-cardiomyocyte cross talk: A dynamic relationship in cardiac biology and pathophysiology, Basic. Res. Cardiol., 112, 6, 10.1007/s00395-016-0598-6 · DOI
  114. Shibamoto, 2019, Activation of DNA Damage Response and Cellular Senescence in Cardiac Fibroblasts Limit Cardiac Fibrosis After Myocardial Infarction, Int. Heart J., 60, 944, 10.1536/ihj.18-701 · DOI
  115. Xie, 2015, Mitochondrial oxidative stress promotes atrial fibrillation, Sci. Rep., 5, 11427, 10.1038/srep11427 · DOI · Paper page
  116. Chang, 2008, Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer, Br. J. Cancer, 99, 1074, 10.1038/sj.bjc.6604676 · DOI · Paper page
  117. Xi, 2012, Eph receptors and ephrins as targets for cancer therapy, J. Cell. Mol. Med., 16, 2894, 10.1111/j.1582-4934.2012.01612.x · DOI · Paper page
  118. Johmura, 2021, Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders, Science, 371, 265, 10.1126/science.abb5916 · DOI · Paper page
  119. Suda, 2022, Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells, Sci. Rep., 12, 6522, 10.1038/s41598-022-10522-3 · DOI · Paper page
  120. Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat. Med., 15, 1082, 10.1038/nm.2014 · DOI · Paper page
  121. Flores, 2001, Tumor susceptibility of p21(Waf1/Cip1)-deficient mice, Cancer Res., 61, 6234
  122. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  123. Zhang, 2011, A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects, Cell Stem Cell, 8, 31, 10.1016/j.stem.2010.12.002 · DOI · Paper page
  124. UK Prospective Diabetes Study (UKPDS) Group (1998). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854–865. · DOI · Paper page
  125. Wang, 2010, Rad as a novel regulator of excitation-contraction coupling and beta-adrenergic signaling in heart, Circ. Res., 106, 317, 10.1161/CIRCRESAHA.109.208272 · DOI · Paper page
  126. Hurez, 2015, Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice, Aging Cell, 14, 945, 10.1111/acel.12380 · DOI · Paper page
  127. Verstovsek, 2010, Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis, N. Engl. J. Med., 363, 1117, 10.1056/NEJMoa1002028 · DOI · Paper page
  128. Sunderland, 2023, Senolytics rejuvenate the reparative activity of human cardiomyocytes and endothelial cells, J. Cardiovasc. Aging, 3, 21
  129. Panchal, 2012, Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats, J. Nutr., 142, 1026, 10.3945/jn.111.157263 · DOI · Paper page
  130. Alfonso, 2022, Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice, Pharmacol. Res., 183, 106356, 10.1016/j.phrs.2022.106356 · DOI
  131. Iske, 2020, Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation, Nat. Commun., 11, 4289, 10.1038/s41467-020-18039-x · DOI · Paper page
  132. Jia, 2020, Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice, J. Cardiovasc. Pharmacol., 76, 452, 10.1097/FJC.0000000000000878 · DOI · Paper page
  133. Xintarakou, 2020, Atrial fibrosis as a dominant factor for the development of atrial fibrillation: Facts and gaps, Europace, 22, 342, 10.1093/europace/euaa009 · DOI
  134. Adili, 2022, Atrial Fibrillation Underlies Cardiomyocyte Senescence and Contributes to Deleterious Atrial Remodeling during Disease Progression, Aging Dis., 13, 298, 10.14336/AD.2021.0619 · DOI
  135. Jesel, L., Abbas, M., Park, S.H., Matsushita, K., Kindo, M., Hasan, H., Auger, C., Sato, C., Ohlmann, P., and Mazzucotelli, J.P. (2019). Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression. J. Clin. Med., 9. · DOI
  136. Wang, 2021, Quercetin improves atrial fibrillation through inhibiting TGF-β/Smads pathway via promoting MiR-135b expression, Phytomedicine, 93, 153774, 10.1016/j.phymed.2021.153774 · DOI
  137. Liu, 2019, Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction, Int. Heart J., 60, 1398, 10.1536/ihj.19-131 · DOI
  138. Xie, 2017, Premature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation, Oncotarget, 8, 57981, 10.18632/oncotarget.19853 · DOI · Paper page
  139. Lee, 2021, Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function, Acta Biomater., 135, 520, 10.1016/j.actbio.2021.08.028 · DOI
  140. Salerno, 2022, Pharmacological clearance of senescent cells improves cardiac remodeling and function after myocardial infarction in female aged mice, Mech. Ageing Dev., 208, 111740, 10.1016/j.mad.2022.111740 · DOI
  141. Makkar, 2012, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial, Lancet, 379, 895, 10.1016/S0140-6736(12)60195-0 · DOI · Paper page
  142. Hare, 2017, Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial, J. Am. Coll. Cardiol., 69, 526, 10.1016/j.jacc.2016.11.009 · DOI · Paper page
  143. Alexandre, 2020, Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines, J. Am. Heart Assoc., 9, e018403, 10.1161/JAHA.120.018403 · DOI · Paper page
  144. Zamorano, 2016, 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC), Eur. Heart J., 37, 2768, 10.1093/eurheartj/ehw211 · DOI · Paper page
  145. Bulten, 2019, Cardiac molecular pathways influenced by doxorubicin treatment in mice, Sci. Rep., 9, 2514, 10.1038/s41598-019-38986-w · doi:10.1038/s41598-019-38986-w
  146. Shi, 2016, Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice, Br. J. Pharmacol., 173, 1517, 10.1111/bph.13453 · DOI · Paper page
  147. Lazaro, 2015, Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice, Diabetes, 64, 3600, 10.2337/db14-1926 · DOI · Paper page
  148. Kim, 2022, A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis, ACS Biomater. Sci. Eng., 8, 1921, 10.1021/acsbiomaterials.1c01611 · DOI
  149. Parvizi, 2021, Senolytic agents lessen the severity of abdominal aortic aneurysm in aged mice, Exp. Gerontol., 151, 111416, 10.1016/j.exger.2021.111416 · DOI
  150. Tateno, 2008, Cell therapy for cardiovascular diseases, Ann. Vasc. Dis., 1, 66, 10.3400/avd.AVDsr00108 · doi:10.3400/avd.avdsr00108
  151. Oda, 2010, Establishment of culturing system for ex-vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia, J. Mol. Cell. Cardiol., 49, 347, 10.1016/j.yjmcc.2010.04.001 · DOI
  152. Tateno, 2006, Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization, Circ. Res., 98, 1194, 10.1161/01.RES.0000219901.13974.15 · DOI · Paper page
  153. Forman, 2021, Cardiovascular care of older adults, Bmj, 374, n1593
  154. Young, 2002, Blood pressure and decline in kidney function: Findings from the Systolic Hypertension in the Elderly Program (SHEP), J. Am. Soc. Nephrol., 13, 2776, 10.1097/01.ASN.0000031805.09178.37 · DOI · Paper page
  155. Izzo, 2000, Clinical Advisory Statement. Importance of systolic blood pressure in older Americans, Hypertension, 35, 1021, 10.1161/01.HYP.35.5.1021 · DOI · Paper page
  156. Higashi, 2012, Endothelial dysfunction and hypertension in aging, Hypertens. Res., 35, 1039, 10.1038/hr.2012.138 · DOI · Paper page
  157. Kawaguchi, 2021, Cellular senescence promotes cancer metastasis by enhancing soluble E-cadherin production, iScience, 24, 103022, 10.1016/j.isci.2021.103022 · DOI
  158. Asaithamby, 2022, Cellular senescence and lung cancer prognosis, Transl. Lung Cancer Res., 11, 1982, 10.21037/tlcr-22-678 · DOI
  159. Mikawa, 2018, Elimination of p19(ARF) -expressing cells protects against pulmonary emphysema in mice, Aging Cell, 17, e12827, 10.1111/acel.12827 · DOI · Paper page
  160. Wyles, 2023, A chronic wound model to investigate skin cellular senescence, Aging, 15, 2852
  161. Dańczak-Pazdrowska, A., Gornowicz-Porowska, J., Polańska, A., Krajka-Kuźniak, V., Stawny, M., Gostyńska, A., Rubiś, B., Nourredine, S., Ashiqueali, S., and Schneider, A. (2023). Cellular senescence in skin-related research: Targeted signaling pathways and naturally occurring therapeutic agents. Aging Cell, e13845. · DOI
  162. Kirkland, 2023, Tumor dormancy and disease recurrence, Cancer Metastasis Rev., 42, 9, 10.1007/s10555-023-10096-0 · DOI
  163. Rahman, 2022, Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition, Mol. Cancer Res., 20, 938, 10.1158/1541-7786.MCR-21-0029 · DOI
  164. Prasanna, 2021, Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy, J. Natl. Cancer Inst., 113, 1285, 10.1093/jnci/djab064 · DOI · Paper page

Cited by

See all 112

Metadata

Authors
Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L.
Venue
Cells
Publisher
MDPI AG
Published
2023-05-02
Volume
12
Issue
9
Pages
1296
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4368405370
Cited by
112
References
138
FWCI
16.22
Type
journal article
Language
en
Open access
gold
Funders
  • US National Institutes of Health (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
  • a Grant-in-Aid for Scientific Research (A) (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
  • Grant-in-Aid for Challenging Research (Pioneering) (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
  • MEXT, AMED-CREST (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
  • the Moonshot Research and Development Program (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
  • Heart Research (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
  • King’s Together Fund Strategic Award, and ‘RENOIR’, the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.